Theory of coherent Bragg spectroscopy of a trapped Bose-Einstein condensate

We present a detailed theoretical analysis of Bragg spectroscopy from a Bose-Einstein condensate at T=0K. We demonstrate that within the linear response regime, both a quantum field theory treatment and a meanfield Gross-Pitaevskii treatment lead to the same value for the mean evolution of the quasiparticle operators. The observable for Bragg spectroscopy experiments, which is the spectral response function of the momentum transferred to the condensate, can therefore be calculated in a meanfield formalism. We analyse the behaviour of this observable by carrying out numerical simulations in axially symmetric three-dimensional cases and in two dimensions. An approximate analytic expression for the observable is obtained and provides a means for identifying the relative importance of three broadening and shift mechanisms (meanfield, Doppler, and finite pulse duration) in different regimes. We show that the suppression of scattering at small values of q observed by Stamper-Kurn et al. [Phys. Rev. Lett. 83, 2876 (1999)] is accounted for by the meanfield treatment, and can be interpreted in terms of the interference of the u and v quasiparticle amplitudes. We also show that, contrary to the assumptions of previous analyses, there is no regime for trapped condensates for which the spectral response function and the dynamic structure factor are equivalent. Our numerical calculations can also be performed outside the linear response regime, and show that at large laser intensities a significant decrease in the shift of the spectral response function can occur due to depletion of the initial condensate.Comment: RevTeX4 format, 16 pages plus 7 eps figures; Update to published version: minors changes and an additional figure. (To appear in Phys. Rev. A

Book Reviews

Review of Prehistory, by Derek Roe; Aspects of Prehistory, by Grahame Clark; World Prehistory, by Grahame Clark; Introductory Readings in Archaeology, by Brian M. Fagan, ed.; The Origins of Civilization, by Carroll L. Riley; The Archaeology of Early Man, by J. M. Coles and E. S. Higgs; Shipwrecks and Archaeology, by Peter Throckmorton; A History of Dyed Textiles, by Stuart Robinson; Food in Antiquity, by Don and Patricia Brothwell; World Archaeology, Vol. 1, nos. 1, 2, 3, by Roy Hodson and Colin Platt, eds.; The Structure and Growth of Australia's Aboriginal Population, by F. Lancaster Jones; Attitudes and Social Conditions, by Ronald Taft, John L. M. Dawson, and Pamela Beasley; Aboriginal Settlements, by J. P. M. Long; The Destruction of Aboriginal Society, by C. D. Rowley; Aboriginal Advancement to Integration, by H. P. Schapper

Relaxation rates and collision integrals for Bose-Einstein condensates

Near equilibrium, the rate of relaxation to equilibrium and the transport properties of excitations (bogolons) in a dilute Bose-Einstein condensate (BEC) are determined by three collision integrals, $\mathcal{G}^{12}$, $\mathcal{G}^{22}$, and $\mathcal{G}^{31}$. All three collision integrals conserve momentum and energy during bogolon collisions, but only $\mathcal{G}^{22}$ conserves bogolon number. Previous works have considered the contribution of only two collision integrals, $\mathcal{G}^{22}$ and $\mathcal{G}^{12}$. In this work, we show that the third collision integral $\mathcal{G}^{31}$ makes a significant contribution to the bogolon number relaxation rate and needs to be retained when computing relaxation properties of the BEC. We provide values of relaxation rates in a form that can be applied to a variety of dilute Bose-Einstein condensates.Comment: 18 pages, 4 figures, accepted by Journal of Low Temperature Physics 7/201

Biodiversity increases the resistance of ecosystem productivity to climate extremes

It remains unclear whether biodiversity buffers ecosystems against climate extremes, which are becoming increasingly frequent worldwide1. Early results suggested that the ecosystem productivity of diverse grassland plant communities was more resistant, changing less during drought, and more resilient, recovering more quickly after drought, than that of depauperate communities2. However, subsequent experimental tests produced mixed results3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13. Here we use data from 46 experiments that manipulated grassland plant diversity to test whether biodiversity provides resistance during and resilience after climate events. We show that biodiversity increased ecosystem resistance for a broad range of climate events, including wet or dry, moderate or extreme, and brief or prolonged events. Across all studies and climate events, the productivity of low-diversity communities with one or two species changed by approximately 50% during climate events, whereas that of high-diversity communities with 16–32 species was more resistant, changing by only approximately 25%. By a year after each climate event, ecosystem productivity had often fully recovered, or overshot, normal levels of productivity in both high- and low-diversity communities, leading to no detectable dependence of ecosystem resilience on biodiversity. Our results suggest that biodiversity mainly stabilizes ecosystem productivity, and productivity-dependent ecosystem services, by increasing resistance to climate events. Anthropogenic environmental changes that drive biodiversity loss thus seem likely to decrease ecosystem stability14, and restoration of biodiversity to increase it, mainly by changing the resistance of ecosystem productivity to climate events

The size of juxtaluminal hypoechoic area in ultrasound images of asymptomatic carotid plaques predicts the occurrence of stroke

Objective: To test the hypothesis that the size of a juxtaluminal black (hypoechoic) area (JBA) in ultrasound images of asymptomatic carotid artery plaques predicts future ipsilateral ischemic stroke. Methods: A JBA was defined as an area of pixels with a grayscale value <25 adjacent to the lumen without a visible echogenic cap after image normalization. The size of a JBA was measured in the carotid plaque images of 1121 patients with asymptomatic carotid stenosis 50% to 99% in relation to the bulb (Asymptomatic Carotid Stenosis and Risk of Stroke study); the patients were followed for up to 8 years. Results: The JBA had a linear association with future stroke rate. The area under the receiver-operating characteristic curve was 0.816. Using Kaplan-Meier curves, the mean annual stroke rate was 0.4% in 706 patients with a JBA <4 mm 2, 1.4% in 171 patients with a JBA 4 to 8 mm2, 3.2% in 46 patients with a JBA 8 to 10 mm2, and 5% in 198 patients with a JBA >10 mm2 (P <.001). In a Cox model with ipsilateral ischemic events (amaurosis fugax, transient ischemic attack [TIA], or stroke) as the dependent variable, the JBA (<4 mm2, 4-8 mm2, >8 mm2) was still significant after adjusting for other plaque features known to be associated with increased risk, including stenosis, grayscale median, presence of discrete white areas without acoustic shadowing indicating neovascularization, plaque area, and history of contralateral TIA or stroke. Plaque area and grayscale median were not significant. Using the significant variables (stenosis, discrete white areas without acoustic shadowing, JBA, and history of contralateral TIA or stroke), this model predicted the annual risk of stroke for each patient (range, 0.1%-10.0%). The average annual stroke risk was <1% in 734 patients, 1% to 1.9% in 94 patients, 2% to 3.9% in 134 patients, 4% to 5.9% in 125 patients, and 6% to 10% in 34 patients. Conclusions: The size of a JBA is linearly related to the risk of stroke and can be used in risk stratification models. These findings need to be confirmed in future prospective studies or in the medical arm of randomized controlled studies in the presence of optimal medical therapy. In the meantime, the JBA may be used to select asymptomatic patients at high stroke risk for carotid endarterectomy and spare patients at low risk from an unnecessary operation

Size Doesn't Matter: Towards a More Inclusive Philosophy of Biology

notes: As the primary author, O’Malley drafted the paper, and gathered and analysed data (scientific papers and talks). Conceptual analysis was conducted by both authors.publication-status: Publishedtypes: ArticlePhilosophers of biology, along with everyone else, generally perceive life to fall into two broad categories, the microbes and macrobes, and then pay most of their attention to the latter. ‘Macrobe’ is the word we propose for larger life forms, and we use it as part of an argument for microbial equality. We suggest that taking more notice of microbes – the dominant life form on the planet, both now and throughout evolutionary history – will transform some of the philosophy of biology’s standard ideas on ontology, evolution, taxonomy and biodiversity. We set out a number of recent developments in microbiology – including biofilm formation, chemotaxis, quorum sensing and gene transfer – that highlight microbial capacities for cooperation and communication and break down conventional thinking that microbes are solely or primarily single-celled organisms. These insights also bring new perspectives to the levels of selection debate, as well as to discussions of the evolution and nature of multicellularity, and to neo-Darwinian understandings of evolutionary mechanisms. We show how these revisions lead to further complications for microbial classification and the philosophies of systematics and biodiversity. Incorporating microbial insights into the philosophy of biology will challenge many of its assumptions, but also give greater scope and depth to its investigations

A review of the Late Permian – Early Triassic conodont record and its significance for the end-Permian mass extinction

As a marine microfossil with a long-lasting fossil record stretching from the Cambrian to the Triassic, the tiny conodont plays an important role for the study of the end-Permian mass extinction. In the past few decades, numerous studies on Permian-Triassic conodonts have been published. This paper summarizes the progress made on high-resolution conodont biostratigraphy, timing of the mass extinction across the Permian-Triassic Boundary, conodont apparatus and phylogeny, conodont size variation, conodont oxygen isotope as well as other isotopes and chemical elements. Finally, future perspectives are also discussed

Effects of rare kidney diseases on kidney failure: a longitudinal analysis of the UK National Registry of Rare Kidney Diseases (RaDaR) cohort

Background Individuals with rare kidney diseases account for 5–10% of people with chronic kidney disease, but constitute more than 25% of patients receiving kidney replacement therapy. The National Registry of Rare Kidney Diseases (RaDaR) gathers longitudinal data from patients with these conditions, which we used to study disease progression and outcomes of death and kidney failure. Methods People aged 0–96 years living with 28 types of rare kidney diseases were recruited from 108 UK renal care facilities. The primary outcomes were cumulative incidence of mortality and kidney failure in individuals with rare kidney diseases, which were calculated and compared with that of unselected patients with chronic kidney disease. Cumulative incidence and Kaplan–Meier survival estimates were calculated for the following outcomes: median age at kidney failure; median age at death; time from start of dialysis to death; and time from diagnosis to estimated glomerular filtration rate (eGFR) thresholds, allowing calculation of time from last eGFR of 75 mL/min per 1·73 m2 or more to first eGFR of less than 30 mL/min per 1·73 m2 (the therapeutic trial window). Findings Between Jan 18, 2010, and July 25, 2022, 27 285 participants were recruited to RaDaR. Median follow-up time from diagnosis was 9·6 years (IQR 5·9–16·7). RaDaR participants had significantly higher 5-year cumulative incidence of kidney failure than 2·81 million UK patients with all-cause chronic kidney disease (28% vs 1%; p<0·0001), but better survival rates (standardised mortality ratio 0·42 [95% CI 0·32–0·52]; p<0·0001). Median age at kidney failure, median age at death, time from start of dialysis to death, time from diagnosis to eGFR thresholds, and therapeutic trial window all varied substantially between rare diseases. Interpretation Patients with rare kidney diseases differ from the general population of individuals with chronic kidney disease: they have higher 5-year rates of kidney failure but higher survival than other patients with chronic kidney disease stages 3–5, and so are over-represented in the cohort of patients requiring kidney replacement therapy. Addressing unmet therapeutic need for patients with rare kidney diseases could have a large beneficial effect on long-term kidney replacement therapy demand. Funding RaDaR is funded by the Medical Research Council, Kidney Research UK, Kidney Care UK, and the Polycystic Kidney Disease Charity